JERSEY, Channel Islands , Sept. 01, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland , today announced that Christian Albrich has been appointed as Chief People Officer of the Company and
JERSEY, Channel Islands , Aug. 11, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Jeremy Stackawitz has notified the Company that he is resigning from his position as Chief Commercial Officer.
MosaiQ™ Solution Transfusion Dx: Latest data confirms performance of MosaiQ Expanded IH; Expanded SDS microarray demonstrates excellent performance Commercial Execution: Significant progress made with several customer evaluations scheduled; 25 separate distributor contacts established New Market
JERSEY, Channel Islands , Aug. 02, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the grant of equity awards to Dr. Michael Hausmann , who has been appointed as the Chief Technology Officer of the Company effective
JERSEY, Channel Islands , July 29, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2021 will be released before market open on Thursday, August 5, 2021 .
JERSEY, Channel Islands , July 02, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Peter Buhler has notified the Company that he is resigning from his position as Chief Financial Officer to take a position with another
New Chief Technology Officer (CTO) appointed to accelerate innovation and further strengthen organizational capabilities Continuing robust progress in advancing the MosaiQ transfusion diagnostics menu Actively preparing for commercialization of MosaiQ products through planned evaluation placements
JERSEY, Channel Islands , May 31, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the management team will participate in two upcoming investor conferences. Jefferies Virtual Healthcare Conference Date: Wednesday, June 2, 2021
JERSEY, Channel Islands , May 25, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2021 will be released before market open on Tuesday, June 1, 2021 .
Transaction proceeds will be used to fund the further development of the MosaiQ platform beyond the Donor Lab and the commercial launch of MosaiQ JERSEY, Channel Islands, May 24, 2021 (GLOBE NEWSWIRE) -- Quotient Limited ("Quotient") (NASDAQ: QTNT), a commercial-stage diagnostics company, today
